Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

362

Participants

Timeline

Start Date

February 21, 2012

Primary Completion Date

April 10, 2016

Study Completion Date

December 20, 2020

Conditions
Nasopharyngeal Neoplasms
Interventions
DRUG

gemcitabine and cisplatin

The GP regimen consists of gemcitabine at a dose of 1,000 mg/m2 by intravenous (i.v.) infusion over 30 min on day 1 and day 8, and cisplatin 80 mg/m2 by i.v. infusion for 4 h on day 1 only

DRUG

5-Fluorouracil and cisplatin

The FP regimen consists of 5-Fluorouracil 1,000 mg/m2/day which was administered as a continuous intravenous infusion for 96 hours after completion of the cisplatin on days 1( 80 mg/m2 i.v. infusion for 4 h)

Trial Locations (1)

510060

Department of Medical Oncology,Cancer Center of Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT01528618 - Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter